1 Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer Clinical Cancer Research, May 24, 2013
2 Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy Journal of Clinical Oncology, June 10, 2013
3 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial The Lancet Oncology, June 12, 2013
4 Contribution of ADAMTS1 as a tumor suppressor gene in human breast carcinoma. Linking its tumor inhibitory properties to its proteolytic activity on Nidogen-1 and Nidogen-2 International Journal of Cancer, May 20, 2013
5 Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? Journal of Cancer Survivorship, May 23, 2013 Review Article
6 Clinical ascertainment of health outcomes among adults treated for childhood cancer JAMA, June 12, 2013 Evidence Based Medicine
7 Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers Annals of Oncology, May 21, 2013
8 Breast density and breast cancer risk by mammogram timing Cancer Epidemiology, Biomarkers & Prevention, May 21, 2013
9 Breast milk' acquired cytomegalovirus infection and disease in VLBW and premature infants Pediatrics, May 28, 2013 Evidence Based Medicine
10 A simple and reproducible prognostic index in luminal ER-positive breast cancers Annals of Oncology, May 29, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor